United States Protein Drugs Market Report 2017

August 2017 | 112 pages | ID: UC0DBCF7793EN
QYResearch

Abstracts

In this report, the United States Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Protein Drugs in these regions, from 2012 to 2022 (forecast).

United States Protein Drugs market competition by top manufacturers/players, with Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Laboratories
• UCB Group
• Schering-Plough Corporation
• Genentech
• Johnson＆Johnson
• Bristol-Myers Squibb
• Novo Nordisk
• Biogen Idec
• Dendreon Corporation
• Amgen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibody Drugs
• Peptide Hormones
• Blood Products
• Enzymes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Protein Drugs for each application, including

• AIDS
• Cancer
• Hepatitis
• Diabetes
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Protein Drugs Market Report 2017

1 PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Protein Drugs
1.2 Classification of Protein Drugs by Product Category
  1.2.1 United States Protein Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Protein Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antibody Drugs
  1.2.4 Peptide Hormones
  1.2.5 Blood Products
  1.2.6 Enzymes
1.3 United States Protein Drugs Market by Application/End Users
  1.3.1 United States Protein Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 AIDS
  1.3.3 Cancer
  1.3.4 Hepatitis
  1.3.5 Diabetes
  1.3.6 Others
1.4 United States Protein Drugs Market by Region
  1.4.1 United States Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Protein Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Protein Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Protein Drugs Status and Prospect (2012-2022)
  1.4.5 New England Protein Drugs Status and Prospect (2012-2022)
  1.4.6 The South Protein Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Protein Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Protein Drugs (2012-2022)
  1.5.1 United States Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Protein Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROTEIN DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Protein Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Protein Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Protein Drugs Market Competitive Situation and Trends
  2.4.1 United States Protein Drugs Market Concentration Rate
  2.4.2 United States Protein Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Protein Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROTEIN DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Protein Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Protein Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Protein Drugs Price by Region (2012-2017)

4 UNITED STATES PROTEIN DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Protein Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Protein Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Protein Drugs Price by Type (2012-2017)
4.4 United States Protein Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROTEIN DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Protein Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Protein Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROTEIN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Protein Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.2 Protein Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 UCB Group
  6.3.2 Protein Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 UCB Group Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Schering-Plough Corporation
  6.4.2 Protein Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Schering-Plough Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech
  6.5.2 Protein Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson＆Johnson
  6.6.2 Protein Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson＆Johnson Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Protein Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.2 Protein Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen Idec
  6.9.2 Protein Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Idec Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Dendreon Corporation
  6.10.2 Protein Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Dendreon Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Amgen

7 PROTEIN DRUGS MANUFACTURING COST ANALYSIS

7.1 Protein Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Protein Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Protein Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Protein Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROTEIN DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Protein Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Protein Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Protein Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Protein Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Protein Drugs
Figure United States Protein Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Drugs Product Picture
Figure Peptide Hormones Product Picture
Figure Blood Products Product Picture
Figure Enzymes Product Picture
Figure United States Protein Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Protein Drugs by Application in 2016
Figure AIDS Examples
Table Key Downstream Customer in AIDS
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Hepatitis Examples
Table Key Downstream Customer in Hepatitis
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Protein Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Protein Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Protein Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Protein Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Protein Drugs Sales Share by Players/Suppliers
Figure 2017 United States Protein Drugs Sales Share by Players/Suppliers
Figure United States Protein Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Protein Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Protein Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Protein Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Protein Drugs Revenue Share by Players/Suppliers
Table United States Market Protein Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Protein Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Protein Drugs Market Share of Top 3 Players/Suppliers
Figure United States Protein Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Protein Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Protein Drugs Product Category
Table United States Protein Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Protein Drugs Sales Share by Region (2012-2017)
Figure United States Protein Drugs Sales Share by Region (2012-2017)
Figure United States Protein Drugs Sales Market Share by Region in 2016
Table United States Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Protein Drugs Revenue Share by Region (2012-2017)
Figure United States Protein Drugs Revenue Market Share by Region (2012-2017)
Figure United States Protein Drugs Revenue Market Share by Region in 2016
Table United States Protein Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Protein Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Protein Drugs Sales Share by Type (2012-2017)
Figure United States Protein Drugs Sales Share by Type (2012-2017)
Figure United States Protein Drugs Sales Market Share by Type in 2016
Table United States Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Protein Drugs by Type (2012-2017)
Figure Revenue Market Share of Protein Drugs by Type in 2016
Table United States Protein Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Protein Drugs Sales Growth Rate by Type (2012-2017)
Table United States Protein Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Protein Drugs Sales Market Share by Application (2012-2017)
Figure United States Protein Drugs Sales Market Share by Application (2012-2017)
Figure United States Protein Drugs Sales Market Share by Application in 2016
Table United States Protein Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Protein Drugs Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Protein Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Protein Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Protein Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Protein Drugs Revenue Market Share in United States (2012-2017)
Table UCB Group Basic Information List
Table UCB Group Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB Group Protein Drugs Sales Growth Rate (2012-2017)
Figure UCB Group Protein Drugs Sales Market Share in United States (2012-2017)
Figure UCB Group Protein Drugs Revenue Market Share in United States (2012-2017)
Table Schering-Plough Corporation Basic Information List
Table Schering-Plough Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales Growth Rate (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales Market Share in United States (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Revenue Market Share in United States (2012-2017)
Table Genentech Basic Information List
Table Genentech Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Protein Drugs Sales Growth Rate (2012-2017)
Figure Genentech Protein Drugs Sales Market Share in United States (2012-2017)
Figure Genentech Protein Drugs Revenue Market Share in United States (2012-2017)
Table Johnson＆Johnson Basic Information List
Table Johnson＆Johnson Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson＆Johnson Protein Drugs Sales Growth Rate (2012-2017)
Figure Johnson＆Johnson Protein Drugs Sales Market Share in United States (2012-2017)
Figure Johnson＆Johnson Protein Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Revenue Market Share in United States (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk Protein Drugs Sales Growth Rate (2012-2017)
Figure Novo Nordisk Protein Drugs Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Protein Drugs Revenue Market Share in United States (2012-2017)
Table Biogen Idec Basic Information List
Table Biogen Idec Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Protein Drugs Sales Growth Rate (2012-2017)
Figure Biogen Idec Protein Drugs Sales Market Share in United States (2012-2017)
Figure Biogen Idec Protein Drugs Revenue Market Share in United States (2012-2017)
Table Dendreon Corporation Basic Information List
Table Dendreon Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales Growth Rate (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales Market Share in United States (2012-2017)
Figure Dendreon Corporation Protein Drugs Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Protein Drugs
Figure Manufacturing Process Analysis of Protein Drugs
Figure Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Protein Drugs Major Players/Suppliers in 2016
Table Major Buyers of Protein Drugs
Table Distributors/Traders List
Figure United States Protein Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Protein Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Protein Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Protein Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Protein Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Protein Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Protein Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Protein Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Protein Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Protein Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Protein Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Protein Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources